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Objectives: Fungal infections in immunocompromised patients have been contributing to the 
increasing morbidity and mortality ofthese patients, especially associated to yeast resistance 
to antifungal therapy. The increase in antibiotic-resistant microorganisms has prompted 
interest in the use of silver as an antimicrobial agent. Thus, the aim of this study was to 
evaluate the antifungal efficacy of silver nanoparticles against Candida a/bicans and Candida 
glabrata biotilms. 
Methods: Spherical nano-silver (average diameter snm) particles were synthesized by silver 
nitrate reduction with sodium citrate. Minimal inhibitory concentration (MIC) tests were 
performed for C. a/bicans (n=2) and C. glabrata ( n=2) grown in suspension using the micro broth 
dilution method. Silver nanoparticles were applied on adhered cells (2 h) or biotilms (48 h) 
and after 24h biotilms were characterized by colony forming units (CFUs) enumeration and 
total biomass quantification (using crystal violet staining). 
Results: Interestingly, C. glabrata MIC values were higher (0.4- 3·3 j.Jg/ml) than C. albicans 
( 0.4- 1.6 jJg/mL). Furthermore, the results obtained revealed that silver nanoparticles were 
more effective in reducing 24h biotilms' biomass when applied onto adhered cells (2h) than 
on pre-formed biofilms (48h), with the exception of C. glabrata clinical isolate, which in both 
cases had a reduction around 90%. Regarding cell viability, silver nanoparticles were highly 
effective on adhered C. glabrata (reduction of around 70%) and respective biotilms (reduction 
of around so%). On C. a/bicans the effect was not so notorious but there was also a reduction 
on the number of biotilm viable cells. 
Conclusion: Silver nanoparticles have great potential to be an effective alternative to 
antifungal agents for future therapies in Candida infections. 
91 
